Fillon, S; Klingel, K; Warntges, S; Sauter, M; Gabrysch, S; Pestel, S; Tanneur, V; Waldegger, S; Zipfel, A; Viebahn, R; +4 more... Haussinger, D; Broer, S; Kandolf, R; Lang, F; (2002) Expression of the serine/threonine kinase hSGK1 in chronic viral hepatitis. Cellular physiology and biochemistry, 12 (1). pp. 47-54. ISSN 1015-8987 DOI: https://doi.org/10.1159/000047826 Full text not available from this repository.

Grieve, R; Roberts, J; (2002) Economic evaluation for hepatitis C. Acta gastro-enterologica Belgica, 65 (2). pp. 104-9. ISSN 0001-5644 https://researchonline.lshtm.ac.uk/id/eprint/17441 Full text not available from this repository.

Hall, AJ; Wild, CP; (2003) Liver cancer in low and middle income countries - Prevention should target vaccination, contaminated needles, and aflatoxins. BMJ (Clinical research ed), 326 (7397). pp. 994-995. ISSN 0959-8138 DOI: https://doi.org/10.1136/bmj.326.7397.994

Judd, A; Hickman, M; Jones, S; McDonald, T; Parry, JV; Stimson, GV; Hall, AJ; (2005) Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ. p. 24. ISSN 1468-5833 DOI: https://doi.org/10.1136/bmj.38286.841227.7C

Kirk, GD; Lesi, OA; Mendy, M; Akano, AO; Sam, O; Goedert, JJ; Hainaut, P; Hall, AJ; Whittle, H; Montesano, R; (2004) The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa. Hepatology (Baltimore, Md), 39 (1). p. 211. ISSN 0270-9139 DOI: https://doi.org/10.1002/hep.20027 Full text not available from this repository.

Lazarus, JV; Lundgren, J; Casabona, J; Wiessing, L; Matheï, C; Vickerman, P; Prins, M; Kretzschmar, M; Kantzanou, M; Giraudon, I; +10 more... Ferri, M; Griffiths, P; Harris, M; Walker, M; Chavdarova, L; Schatz, E; Schiffer, K; Kools, JP; Farell, J; Mendão, L; (2014) Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis. BMC infectious diseases, 14 (Suppl). S18-S18. ISSN 1471-2334 DOI: https://doi.org/10.1186/1471-2334-14-S6-S18

Mateu-Gelabert, P; Treloar, C; Calatayud, VA; Sandoval, M; Zurian, JCV; Maher, L; Rhodes, T; Friedman, SR; (2007) How can hepatitis C be prevented in the long term? The International journal on drug policy, 18 (5). pp. 338-340. ISSN 0955-3959 DOI: https://doi.org/10.1016/j.drugpo.2007.06.001 Full text not available from this repository.

Nascimento, MC; Mayaud, P; Sabino, EC; Torres, KL; Franceschi, S; (2008) Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: A multi-center serosurvey. Journal of medical virology, 80 (1). pp. 53-57. ISSN 0146-6615 DOI: https://doi.org/10.1002/jmv.21046 Full text not available from this repository.

Rhodes, SD; Diclemente, RJ; Yee, LJ; Hergenrather, KC; (2001) Factors associated with testing for hepatitis C in an internet-recruited sample of men who have sex with men. Sexually transmitted diseases, 28 (9). pp. 515-20. ISSN 0148-5717 DOI: https://doi.org/10.1097/00007435-200109000-00007 Full text not available from this repository.

Rozman, MA; Alves, IS; Porto, MA; Gomes, PO; Ribeiro, NM; Nogueira, LAA; Caseiro, MM; da Silva, VA; Massad, E; Burattini, MN; (2007) HIV and related infections in a sample of recyclable waste collectors of Brazil. International journal of STD & AIDS, 18 (9). pp. 653-654. ISSN 0956-4624 DOI: https://doi.org/10.1258/095646207781568574 Full text not available from this repository.

Ruf, M; Cohuet, S; Maguire, H; Brant, LJ; Ramsay, M; Lattimore, S; Delpech, V; SNAHC Steering Group; (2008) Situation of HIV infections and STIs in the United Kingdom in 2007. Euro surveillance, 13 (47). ISSN 1025-496X https://researchonline.lshtm.ac.uk/id/eprint/2319288

Schmidt, AJ; Rockstroh, JK; Vogel, M; An der Heiden, M; Baillot, A; Krznaric, I; Radun, D; (2011) Trouble with bleeding: risk factors for acute hepatitis C among HIV-positive gay men from Germany--a case-control study. PloS one, 6 (3). e17781. ISSN 1932-6203 DOI: https://doi.org/10.1371/journal.pone.0017781

Sutton, AJ; Edmunds, WJ; Gill, ON; (2006) Estimating the cost-effectiveness of detecting cases of chronic hepatitis C infection on reception into prison. BMC public health, 6. p. 170. ISSN 1471-2458 DOI: https://doi.org/10.1186/1471-2458-6-170

Sweeting, MJ; de Angelis, D; Brant, LJ; Harris, HE; Mann, AG; Ramsay, ME; (2007) The burden of hepatitis C in England. Journal of viral hepatitis, 14 (8). pp. 570-576. ISSN 1352-0504 DOI: https://doi.org/10.1111/j.1365-2893.2007.00851.x Full text not available from this repository.

Thomson, BJ; Kwong, G; Ratib, S; Sweeting, M; Ryder, SD; de Angelis, D; Grieve, R; Irving, WL; (2008) Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management. Journal of viral hepatitis, 15 (4). pp. 271-278. ISSN 1352-0504 DOI: https://doi.org/10.1111/j.1365-2893.2007.00941.x Full text not available from this repository.

Yee, LJ; Perez, KA; Tang, J; van Leeuwen, DJ; Kaslow, RA; (2003) Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection. The Journal of infectious diseases, 187 (8). pp. 1264-71. ISSN 0022-1899 DOI: https://doi.org/10.1086/374561 Full text not available from this repository.

van Leeuwen, DJ; Yee, LJ; Langner, RG; (2002) 24 weeks of interferon-ribavirin therapy should not routinely be given to all hepatitis C patients. The American journal of gastroenterology, 97 (2). pp. 497-8. ISSN 0002-9270 DOI: https://doi.org/10.1016/S0002-9270(01)04074-6 Full text not available from this repository.